Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07Submission of Matters to a Vote of Security Holders.
Our Annual Meeting of Stockholders was held on May 16, 2017 (the
Annual Meeting). We had 49,836,070 shares of common stock
outstanding on March 28, 2017, the record date for the Annual
Meeting. At the Annual Meeting, 41,859,984 shares of common stock
were present in person or represented by proxy. The following
sets forth the final results of the voting for the matters voted
upon at the Annual Meeting. These matters are described in more
detail in our definitive proxy statement, dated April 6, 2017.
Proposal 1:Election of three members of the Board of Directors of
the Company. The shareholders elected three directors to hold
office until the 2020 Annual Meeting of Stockholders, or until
their successors are duly elected and qualified, by the following
votes:
Name of Director Elected |
For |
Withheld |
Broker Non-Votes |
|||
Kim D. Blickenstaff |
26,772,905 |
1,355,205 |
13,731,874 |
|||
Howard E. Greene, Jr. |
26,726,965 |
1,401,145 |
13,731,874 |
|||
Christopher J. Twomey |
26,812,646 |
1,315,464 |
13,731,874 |
Proposal 2:Ratification of the appointment of Ernst Young LLP to
serve as the independent registered public accountant for the
2017 fiscal year. The proposal was approved, by the following
vote:
For |
Against |
Abstain |
Broker Non-Votes |
||||
41,643,496 |
197,477 |
19,011 |
2
About Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump’s cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters. Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Recent Trading Information
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) closed its last trading session up +0.005 at 0.905 with 175,089 shares trading hands.